{"entity":{"id":"t-cell-states","kind":"term","name":"T-cell states","aka":[],"tldr":"Response history and measured function help describe a T cell's state. One marker cannot provide a complete label.","summary":"Naive, effector, memory and exhausted populations describe response histories and differentiation programmes, not one mandatory sequence for every T cell. Anergy and exhaustion are distinct mechanisms. Regulatory function is a separate role. Identity, location, receptor specificity, state and measured function are complementary observations.\n\nIn chronic viral infection in mice, TCF1-associated progenitor populations sustained responses and supplied the proliferative burst after PD-1 blockade. In tumour models, progenitor exhausted cells differed from terminally exhausted cells; the related melanoma observations were associations rather than a universal treatment-selection rule. Progenitor-like exhaustion is not ordinary memory. A shared receptor does not require a shared functional phenotype, and PD-1 or TCF1 alone does not establish state or tumour specificity.\n\nPaired human skin-cancer biopsies after PD-1 blockade showed expanded clonotypes not previously observed in the same tumour, supporting clonal replacement as another response model. Absence from an earlier sample does not establish absence throughout the body. A fictional PD-1-positive population near cancer can include viral-reactive and tumour-peptide-reactive cells. Neither proximity nor peptide response proves natural tumour recognition or killing. Preserve response history, sampling site, time, multiple markers and controlled function; neither division nor a favourable pattern predicts individual benefit.","asOf":"2026-11-12","links":[{"label":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection.","url":"https://pubmed.ncbi.nlm.nih.gov/17950003/"},{"label":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.","url":"https://pubmed.ncbi.nlm.nih.gov/27501248/"},{"label":"T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.","url":"https://pubmed.ncbi.nlm.nih.gov/27533016/"},{"label":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.","url":"https://pubmed.ncbi.nlm.nih.gov/30778252/"},{"label":"Clonal replacement of tumor-specific T cells following PD-1 blockade.","url":"https://pubmed.ncbi.nlm.nih.gov/31359002/"},{"label":"Linking T-cell receptor sequence to functional phenotype at the single-cell level.","url":"https://pubmed.ncbi.nlm.nih.gov/24952902/"},{"label":"Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans.","url":"https://pubmed.ncbi.nlm.nih.gov/22365666/"},{"label":"Burger et al., model-antigen dominance and TCF1 subsets","url":"https://pubmed.ncbi.nlm.nih.gov/34534464/"},{"label":"Henson et al.: proliferation, effector proteins and metabolism in human CD8 subsets (2014)","url":"https://pubmed.ncbi.nlm.nih.gov/25083993/"},{"label":"Pereira et al.: NK-like killing by defined senescent-like CD8 cells (2020)","url":"https://pubmed.ncbi.nlm.nih.gov/32231301/"}],"tags":[],"related":["t-cell"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Naive describes absence of initial antigen-driven activation, not recent thymic birth. Effector denotes developed response functions, including help or killing; memory can support renewed responses but promises neither permanent protection nor cancer specificity. State categories are not one mandatory developmental trajectory. Anergy, exhaustion, external suppression and regulatory role remain distinct.","The same paired receptor can occur with different functional phenotypes and response histories. Fictional R1 memory-associated and progenitor-like exhausted observations are separate observations, not a measured transition. Progenitor-like exhaustion is distinct from ordinary memory; shared TCF1 or division does not make their programmes equivalent.","Two fictional six-symbol PD-1-positive populations near cancer have different controlled peptide responses: one viral and one tumour-peptide directed. Marker and proximity do not establish specificity; peptide response does not establish natural tumour display, access or killing. Checkpoint blockade does not rewrite receptor specificity. Preserve tissue, sampling time, population definitions and controlled function alongside RNA/protein panels; favourable markers or division alone cannot predict benefit.","Source scope: teaching synthesis checked against the cited abstracts and specified accessible primary text on 9 November 2026; fictional examples are not clinical observations or treatment-selection rules.","In Burger and colleagues' engineered mouse lung tumours, the subdominant response contained heterogeneous TCF1-positive populations, including a CCR6/Tc17-associated subset that did not preferentially benefit from checkpoint blockade. Long-peptide vaccination with the two model antigens and cyclic di-GMP improved the subdominant response; a subdominant-only arm also tested antigen-specific effects. The separate human analyses were associations, not a validated universal TCF1/CCR6 requirement, target-deletion rule or clone-pruning instruction.","Reduced division and immediate effector activity are separate measurements. In healthy-donor CD8 subsets, Henson and colleagues measured reduced proliferation alongside cytokine, perforin and granzyme expression; that protein panel alone is not a direct target-death assay, and not every EMRA cell carried the measured senescence markers. Pereira and colleagues separately demonstrated killing by defined senescent-like CD27-negative/CD28-negative CD8 cells, including MHC-I-deficient targets and NKG2D-DAP12-associated NK-like activity. These observations do not establish conventional tumour-specific TCR killing, durable control or clinical benefit for every highly differentiated cell."],"category":"Immunology"},"route":"/terms/t-cell-states/","neighbours":{"term":[{"id":"t-cell","kind":"term","name":"T cell","route":"/terms/t-cell/"}]}}